Portfolio products Buprenorphine HCl CAS No.: 53152-21-9 Specification: Ph.Eur & USP Regulatory Status: CEP + USDMF (applied) EU SDS Dexamfetamine sulphate CAS No.: 51-63-8 Specification: N/A Regulatory Status: CEP EU SDS Buprenorphine CAS No.: 52485-79-7 Specification: Regulatory Status: CEP + USDMF (applied) EU SDS Dexamfetamine (base) CAS No.: 51-64-9 Specification: Ph.Eur Regulatory Status: Starting material EU SDS Tolfenamic Acid CAS No.: 13710-19-5 Specification: Ph.Eur Regulatory Status: CEP EU SDS Hydromorphone HCL CAS No.: 71-68-1 Specification: Ph.Eur Regulatory Status: CEP EU SDS Products under development Apomorphine HCl CAS No.: 41372-20-7 Specification: Ph.Eur Regulatory Status: N/A EN SDS Sugammadex CAS No.: 343306-79-6 Specification: Ph.Eur Regulatory Status: N/A Naloxone CAS No.: 357-08-4 Specification: Ph.Eur Regulatory Status: N/A